A carregar...
Comparison between three oxaliplatin-based regimens with bevacizumab in patients with metastatic colorectal cancer
BACKGROUND: A previous pivotal Phase III study (NO16966) demonstrated the benefit of the addition of bevacizumab (BV) to oxaliplatin-based regimens in metastatic colorectal cancer (MCRC). Our study evaluated the safety and efficacy of three oxaliplatin-based chemotherapy regimens (FOLFOX4 [intraveno...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354450/ https://ncbi.nlm.nih.gov/pubmed/25767397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S77190 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|